Calvin Bradley 4
4 · GenMark Diagnostics, Inc. · Filed Jan 5, 2012
Insider Transaction Report
Form 4
Calvin Bradley
Senior VP, Global Marketing
Transactions
- Award
Common Stock
2012-01-03$4.38/sh+20,537$89,952→ 20,537 total - Award
Stock Option (Right to Buy)
2012-01-03+32,500→ 32,500 totalExercise: $4.38Exp: 2022-01-03→ Common Stock (32,500 underlying)
Footnotes (2)
- [F1]25% of the shares vest on October 3, 2012 and the remaining restricted stock vests in 12 quarterly installments thereafter.
- [F2]25% of the option shares vest and become exercisable on October 3, 2012 and the remaining option shares vest and become exercisable in 36 monthly installments thereafter.